Doxy-Post-exposure Prophylaxis

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

September 25, 2024

Study Completion Date

December 24, 2024

Conditions
Sexually Transmitted Diseases
Interventions
DRUG

Doxycycline

Doxycycline is used to treat or prevent infections that are strongly suspected to be caused by bacteria; it is an antimicrobial drug indicated for bacterial infections such as sexually transmitted infections. Doxycycline (DOX) will be given orally at 100 and 200 mg doses.

Trial Locations (1)

30322

Hope Clinic, Atlanta

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Emory University

OTHER

NCT05853120 - Doxy-Post-exposure Prophylaxis | Biotech Hunter | Biotech Hunter